Margaret Mitchell: Unfiltered

Celcuity prepares for a key fireside chat at Guggenheim's 2026 summit, with investors eyeing crucial updates on its lead cancer drug, gedatolisib.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?

As OneMain CEO Doug Shulman prepares for a key conference, all eyes are on the lender's strategy for navigating a complex economic and regulatory landscape.

With new CPO and CRO hires, Limble signals an aggressive push to scale its AI maintenance platform and cement its leadership in a competitive industry.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Promega's new diagnostic for KEYTRUDA gains NMPA approval, opening doors for targeted solid tumor therapy amid China's growing precision medicine market.

Record revenue and a bullish forecast overshadowed a massive one-time charge, as the firm's core industrial businesses show powerful underlying strength.

Celanese completes a key divestiture to tackle its massive debt, while buyer Element Solutions bolsters its high-growth electronics portfolio.

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

A $6.8M judgment against a VA claims company reveals a battle for ethics, spurring laws to protect veterans from deceptive and costly practices.

The French data science leader's first acquisition signals a major play in the AI consolidation game, aiming to fuse strategic ROI with granular customer analytics.

Just in time for the Super Bowl, BART launches Wi-Fi 6E at key hubs, promising a new era of connectivity for millions of Bay Area riders.

The RegTech firm, once a cannabis banking specialist, unveils a major rebrand and expands its platform to tackle digital assets and Money Services Businesses.

Shane Kovacs's exit from Olema Oncology introduces leadership questions as the biotech firm nears a pivotal data readout for its lead breast cancer drug.

Asante Gold boosts its war chest with a C$13.8M private placement led by its own chairman, fueling aggressive expansion at its Ghanaian gold mines.

An Austin-based tech company's platform, which integrates into doctors' workflows, has cut prescription costs for nearly 60,000 Ohio residents.

SKF nominates tech and global operations veterans from Airbus and Bosch, signaling a major focus on digitalization and efficiency amid a corporate overhaul.

As threats to OT surge, Dragos's hire of Dawn Mitchell signals a strategic shift: winning the war for talent is key to safeguarding civilization.

CarParts.com outsources its Manila operations to an AI specialist, a strategic move signaling a new era of efficiency, cost-cutting, and workforce evolution.